Bristol-Myers Squibb Co. Ups Forecast As Q1 Earnings Beat The Street

Bristol-Myers Squibb Co. early Thursday posted much better than expected first quarter earnings results and lifted its full-year outlook, as sales of several of its new drugs begin to skyrocket.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.